We used special silicone molds produced by our collaborators at THeraject to create the microneedles containing a dried version of a live modified adenovirus-based candidate HIV vaccine in the sugar formulation.
Prof Gary Tearney, one of the research collaborators, said the technology is cheaper than endoscopy and avoids the need for sedation, specialised equipment or special training.